Short answer · Medically reviewed summary · Last updated: 2026-05-08
Macular degeneration, specifically age-related macular degeneration (AMD), is a common condition affecting approximately 200 million people globally, with prevalence expected to rise significantly as the population ages. While often categorized as a common condition rather than a rare disease, specific genetic forms of macular degeneration, such as Stargardt disease, are classified as rare, highlighting the importance of precise clinical diagnosis. Is macular degeneration considered a common or rare disease? While the most prevalent form, age-related macular degeneration, is a leading cause of vision loss in older adults globally, it is not considered a rare disease.
What is the prevalence of Macular Degeneration?
Prevalence of Macular Degeneration: how many people are affected worldwide, differences by sex and region, with sources.
Macular degeneration, specifically age-related macular degeneration (AMD), is a common condition affecting approximately 200 million people globally, with prevalence expected to rise significantly as the population ages. While often categorized as a common condition rather than a rare disease, specific genetic forms of macular degeneration, such as Stargardt disease, are classified as rare, highlighting the importance of precise clinical diagnosis.
Is macular degeneration considered a common or rare disease?
While the most prevalent form, age-related macular degeneration, is a leading cause of vision loss in older adults globally, it is not considered a rare disease. However, the term macular degeneration encompasses a broad spectrum of conditions, including juvenile forms like Best disease or Stargardt disease, which are classified as rare genetic disorders. Data from the DiseaseMaps.org community reflects this diversity, with 9 members currently sharing their lived experiences with various forms of macular degeneration.
What are the demographic and geographic prevalence trends?
Epidemiological data indicates that macular degeneration prevalence is influenced by age, ethnicity, and gender:
- Age of Onset: The risk increases exponentially after age 50; however, juvenile macular degeneration can present in childhood or early adulthood.
- Gender Distribution: Women are statistically more likely to be diagnosed with late-stage macular degeneration than men, partly due to longer life expectancy.
- Ethnic Variations: Studies suggest higher prevalence rates among individuals of European descent compared to those of African or Asian descent.
Why is accurate prevalence data for macular degeneration challenging?
Accurate tracking of macular degeneration is complicated by asymptomatic early stages and the varying criteria used in global clinical studies. Many individuals remain undiagnosed until significant vision loss occurs. Furthermore, distinguishing between age-related forms and rare genetic maculopathies often leads to misclassification in large-scale epidemiological registries, meaning the "true" prevalence of specific rare genetic variants is likely underreported.
Next steps
- Schedule a comprehensive dilated eye exam with a retina specialist to confirm your specific diagnosis.
- Consult a genetic counselor if you suspect a hereditary form of macular degeneration.
- Join the DiseaseMaps.org community to connect with others and share real-world insights into living with the condition.
- Review clinical trial registries such as ClinicalTrials.gov if you are seeking information on emerging therapeutic interventions.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH National Eye Institute (NEI): Age-Related Macular Degeneration Data.
- Orphanet: Rare Maculopathies and Genetic Retinal Disorders.
- The Lancet Global Health: Global prevalence of age-related macular degeneration (meta-analysis).
- American Academy of Ophthalmology (AAO): Clinical Guidelines for Retinal Disease.
